royalty pharma stock price target

Last 18 months Recommendations Chart ROYALTY PHARMA PLC. Royalty Pharma PLC analyst estimates including RPRX earnings per share estimates and analyst recommendations.

Royalty Pharma Nasdaq Rprx Has Announced That It Will Be Increasing Its Dividend To Us 0 19

ET by Tomi Kilgore Royalty Pharma started at buy with 56 stock price target at.

. 13 2020 at 813 am. According to 14 stock analysts the average 12-month stock price forecast for RPRX stock is 5291 which predicts an increase of 3388. Royalty Pharmas investors also received annual dividends of about 25 of the businesss free cash flow.

Stock quotes are provided by Factset Morningstar and SP Capital IQ. Negative dynamics for Royalty Pharma shares will prevail with possible volatility of. A B is better than a C.

And since 2012 Royalty Pharmas cash receipts jumped at an annual rate of around 11. Analyst Recommendations on ROYALTY PHARMA PLC. Evolution of the average Target Price on ROYALTY PHARMA PLC.

The average price target is 5080 with a high forecast of 5600 and a low forecast of 4800. Following the IPO the quarterly dividend is now 15 cents a share. The lowest target is 4848 and the highest is 5985.

Stock Price Target RPRX. Royalty Pharma PLC RPRX NASDAQ. The 10 analysts offering price forecasts for Royalty Pharma have a median target of 5094 with a high estimate of 5600 and a low estimate of 4244.

Average price target from 10 ratings. 2734 Upside Based on 6 Wall Street analysts offering 12 month price targets for Royalty Pharma in the last 3 months. According to the issued ratings of 6 analysts in the last year the consensus rating for Royalty Pharma stock is Buy based on the current 6 buy ratings for RPRX.

The 9 analysts offering 12-month price forecasts for Royalty Pharma PLC have a median target of 5100 with a high estimate of 5800 and a low estimate of 4800. 6 Wall Street analysts that have issued a 1 year RPRX price target the average RPRX price target is 5000. The average ROYALTY PHARMA stock price prediction forecasts a potential upside of 2435 from the current RPRX share price of 4021.

6 equities research analysts have issued 12 month price targets for Royalty Pharmas shares. Royalty Pharma said in a regulatory filing it plans to offer 70 million shares at a target price range of 25-28 per share. Try a valid symbol or a specific company.

Analyst Price Target on RPRX. Learn more on RPRXs analyst rating history. Forecast target price for 06-14-2022.

This chart shows the closing price for RPRX for the. Royalty Pharma PLC analyst ratings historical stock prices earnings estimates actuals. And a D is better than an F.

This suggests a possible upside of 238 from the stocks current price. Royalty Pharma Stock Forecast 06-14-2022. View real-time RPRX stock price and news along with industry-best analysis.

Stock analysis for Royalty Pharma PLC RPRXNASDAQ GS including stock price stock chart company news key statistics fundamentals and company profile. Royalty Pharma plcs average analyst price target is greater than 8077 of stocks in the large market cap category. View the latest Royalty Pharma PLC RPRX stock price news historical charts analyst ratings and financial information from WSJ.

The average price target represents a 1930 upside from the last price of 4258. Target Price consensus revisions. The median estimate represents a 7958.

RPRX IEX Real-Time Price USD. 721a Northern Trust stock price target cut to. The average price target is 5160 with a high forecast of 5600 and a low forecast of 4800.

Their forecasts range from 4800 to 5600. As an investor you want to. The net income jumped from 580 million in 2015 to 235 billion last year.

In terms of price targets and recommendations offered by analysts the stocks in the Pharmaceutical Products industry with the ratings most similar to Royalty Pharma plc are REGN RDY and RARE. On average analysts rate RPRX stock as a. Complete Royalty Pharma PLC stock information by Barrons.

View analysts price targets for Royalty. Find the latest Royalty Pharma plc RPRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Royalty Pharma started at neutral with 50 stock price target at JP.

An A is better than a B. What is RPRXs Earnings Per Share EPS forecast for 2022-2024. The average twelve-month price prediction for Royalty Pharma is 5114 with a high price target of 5600 and a low price target of 4800.

Find the latest Royalty Pharma plc RPRX stock quote history news and other vital information to help you with your stock trading and investing. The average price target represents a 2734 change from the last price of 4052. A C is better than a D.

RPRX updated stock price target summary. This price target is based on 5 analysts offering 12 month price targets for Royalty Pharma in the last 3 months. On average they anticipate Royalty Pharmas stock price to reach 5114 in the next year.

The top end of the range values the company at.

Insider Selling Royalty Pharma Plc Nasdaq Rprx Director Sells 26 304 Shares Of Stock Defense World